Trying to conceive · 5 min · sourced
BBT confirms a temperature rise occurred after ovulation, indicating a corpus luteum formed and progesterone is being released. That temperature shift shows ovulation happened — past tense. By the time your temperature goes up, the fertile window has closed.
A biphasic chart — low temperatures in the follicular phase, then sustained higher temperatures after ovulation — is reassuring evidence that you're ovulating regularly. But it's only one piece of the fertility picture. BBT cannot predict when ovulation will happen, so it's not useful for timing intercourse in the current cycle.
The temperature rise tells you nothing about whether the egg released is healthy, whether your fallopian tubes are open, whether sperm can reach the egg, or whether your uterine lining is receptive.
BBT confirms an egg was released, but tells you nothing about that egg's quality or chromosomal health. Maternal age is the strongest predictor of egg quality. As you get older, the proportion of chromosomally abnormal eggs increases — regardless of whether your temperature charts look perfect.
Ovarian reserve — how many eggs you have left — is measured by AMH (anti-Müllerian hormone), FSH (follicle-stimulating hormone on day 3 of your cycle), and antral follicle count via transvaginal ultrasound. A woman with diminished ovarian reserve may still ovulate regularly and produce a normal BBT chart each month.
Blocked or damaged fallopian tubes account for a substantial portion of female infertility cases. BBT provides no information about tubal patency. Even with confirmed ovulation, if one or both tubes are blocked, sperm and egg cannot meet.
Male factor contributes to roughly half of infertility cases. Semen analysis evaluates sperm concentration, motility, and morphology. Even if you're ovulating perfectly, conception cannot happen if sperm parameters are suboptimal. BBT tells you nothing about sperm health.
Many couples with confirmed ovulation, open tubes, and normal semen still fail to conceive — a category called unexplained infertility. This proves that ovulation alone is necessary but not sufficient.
The temperature rise confirms progesterone is being produced after ovulation. But the size of the temperature rise — whether it's 0.3°F or 0.6°F — does not directly correlate with progesterone levels.
BBT can show a short luteal phase if you see fewer than 10 days of elevated temperatures before your period starts, which may suggest insufficient progesterone production. But luteal phase adequacy is more accurately assessed by a mid-luteal progesterone blood test, typically done around day 21 in a 28-day cycle. This test directly measures progesterone levels rather than inferring them from temperature.
The fertile window is the six-day period ending on ovulation day. BBT only rises after that window has closed. By the time your temperature shifts, the egg has already been released and has a 12–24 hour lifespan.
Methods that identify the fertile window before ovulation are more effective for timing intercourse. Cervical mucus becomes clear, stretchy, and abundant in the days before ovulation. LH surges 24–36 hours before the egg is released. Both give you prospective information.
BBT is useful for confirming ovulation happened, but it's a retrospective tool.
Sokkai provides guidance matched to your specific phase — not generic lifestyle advice. See how Sokkai works →
Ovarian reserve testing assesses egg quantity through blood tests on specific cycle days and an ultrasound to count developing follicles. These tests tell you how many eggs remain and how your ovaries are likely to respond to stimulation if you need fertility treatment.
Tubal patency assessment confirms your fallopian tubes are open. Hysterosalpingography (HSG) is an X-ray procedure where contrast dye is injected through the cervix and tracked as it fills the uterus and spills through the tubes.
Semen analysis evaluates sperm concentration, motility, and morphology. At least one analysis is essential; ideally two if the first is abnormal, given variability between samples.
Mid-luteal progesterone is a blood test done around day 21 in a 28-day cycle (or 7 days after suspected ovulation) to confirm adequate progesterone production.
ACOG and ASRM recommend fertility evaluation after 12 months of trying if you're under 35, or after 6 months if you're 35 or older. If you have known risk factors — irregular cycles, history of pelvic infection, endometriosis, prior pelvic or abdominal surgery — start evaluation sooner regardless of age.
BBT can be part of the picture when you see your doctor. Bringing your charts to your first appointment shows ovulation is happening and provides useful cycle-length data. But it's not a substitute for testing. The standard fertility workup addresses all the factors BBT can't assess: egg reserve, tubal patency, sperm health, and hormonal adequacy.
Women with perfect BBT charts still need comprehensive evaluation if conception hasn't happened within the recommended timeframe.
Seek medical evaluation if you've been trying to conceive for 12 months without success (or 6 months if you're 35 or older). But some situations warrant earlier assessment. See a doctor sooner if your cycles are irregular or absent, if you have severe pelvic pain or a history of pelvic infection or sexually transmitted infection, if you've had prior pelvic or abdominal surgery, if you have known or suspected endometriosis, or if your male partner has a history of fertility concerns or prior treatment. If you've been tracking BBT and confirmed ovulation but conception hasn't occurred within the recommended timeframe, a comprehensive workup is the next step.
Ovarian reserve tests (AMH, FSH, antral follicle count) were developed primarily to predict how well ovaries will respond to stimulation during IVF treatment. Their ability to predict natural conception rates is less clear — a woman with low AMH may still conceive naturally, and a woman with normal AMH may still face difficulty. These tests tell us about egg quantity, but we still lack reliable clinical tests that directly assess egg quality or embryo potential in a natural conception context.
Unexplained infertility — diagnosed when all standard testing is normal but conception doesn't occur — affects up to 30% of infertile couples. We don't fully understand why ovulation, tubal patency, and normal semen analysis are sometimes not enough. Research into uterine receptivity, sperm DNA integrity, and immune factors continues, but these areas remain less well-defined than the standard workup.
Sokkai's AI coach knows where you are in the transition and adapts its guidance to your actual pattern — not a one-size-fits-all plan.
Try Sokkai free